Chronic hyperglycemia inhibits vasoregression in a transgenic model of retinal degeneration

Y Feng1, Y Wang, Z Yang

  • 15th Medical Clinic, Faculty of Clinical Medicine, University of Heidelberg, Mannheim, Germany, yuxi.feng@medma.uni-heidelberg.de.

Acta Diabetologica
|June 18, 2013
PubMed

Insights

Chronic hyperglycemia surprisingly protected retinal vasculature and neurons in a diabetic rat model. This suggests diabetes may offer vasoprotection, with retinal glia playing a key role.

Area of Science:

  • Ophthalmology
  • Diabetology
  • Neuroscience

Background:

  • Diabetic retinopathy involves vasoregression, a process also seen in ciliopathy-induced retinal neurodegeneration.
  • Previous studies showed earlier vasoregression in TGR rats with ciliopathy-induced neurodegeneration.

Purpose of the Study:

  • To investigate the interplay between chronic hyperglycemia and photoreceptor degeneration on adult vascular remodeling.
  • To assess the vasoprotective effects of diabetes in a neurodegenerative retinal model.

Main Methods:

  • Streptozotocin-induced diabetes in TGR rats, analyzed at 4 and 9 months.
  • Quantitative retinal morphometry for vasoregression assessment.
  • Measurement of retinal VEGF levels, glial activation, and HSP27 expression via ELISA and immunofluorescence.

Main Results:

  • Reduced acellular capillaries and fewer microvascular abnormalities in diabetic TGR rats.
  • Preservation of inner nuclear layers (INLs) from cell loss in diabetic TGR rats.
  • Increased VEGF levels and upregulated HSP27 expression in retinal glia of diabetic TGR rats.

Conclusions:

  • Chronic hyperglycemia demonstrated a vasoprotective effect in this retinal neurodegeneration model.
  • Cell preservation in the INL was linked to protective gene regulation.
  • Retinal glia may play a significant role in mediating diabetes-induced vasoprotection.

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...